Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00201799
Status:
COMPLETED
Last Update Posted:
2015-06-10
First Post:
2005-09-12
Brief Title:
Infliximab for the Prevention of Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation
Sponsor:
Ohio State University Comprehensive Cancer Center
Organization:
Ohio State University Comprehensive Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Graft-Versus-Host Disease |
Keywords:
| Name | View |
|---|---|
| Hematopoietic Stem Cell Transplantation | View |